Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 30 November, 2020

FIL Limited

Form 8.3 - Willis Towers Watson Plc

RNS Number : 9654G
FIL Limited
30 November 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

Companydealtin

WILLIS TOWERS WATSON PLC

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

ORDINARY SHARES

of dealing

27-November-2020

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

 

 

 

(1)Relevantsecurities

 1,991,098   1.54%

 

Derivatives than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 1,991,098   1.54%

 

             

 

 

THE ABOVE INCLUDES A TRANSFER OUT OF 20 ORDINARY SHARES.

 

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:

Long

Short

 

 

 

(1)Relevantsecurities

 

 

 

Derivatives than options)

 

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap20

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (Note 5)

 Sale

 200

 209.48 USD/Share

 Purchase

 1,408

 210.26 USD/Share

 Sale

 269

 210.79 USD/Share

 Purchase

 14

 211.08 USD/Share

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

CFD

Natureoftransaction

6)

Numberofrelevantsecurities

7)

Priceperunit

5)

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

of transaction

8)

per unit

 

 

 

Ap21

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 
any other person relating to the voting rights of any relevant securities under any option referred to 
on this form or relating to the voting rights or future acquisition or disposal of any relevant 
securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

30-November-2020

Contact name

Paul Clark

Telephone number

00353 1 223 1447

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEKZMFMFGRGGZM

a d v e r t i s e m e n t